NCT05435144

Elderberry for Immune Support

The Effects of Supplementation With ElderCraft® Elderberry Extract: A Randomized, Triple-blind, Placebo Controlled Clinical Trial.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 420 (estimated)
• Sponsor: Nutraceuticals Research Institute · Academic / Other
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to confirm and quantify the effects of ElderCraft® elderberry extract on immune health.

Detailed description

This study is a randomized double blind, placebo controlled clinical trial. The purpose is to evaluate the between-groups difference in incidence and duration of upper respiratory events and severity of upper respiratory symptoms while supplementing with ElderCraft® elderberry extract. After attending an orientation session, participants will provide informed consent and be randomized on a 1:1 basis into an intervention group or a placebo group. Each group will consume two capsules daily for 13 weeks. Each intervention capsule contains 300 mg of European black elderberry extract, standardized to 15% anthocyanins.

Conditions

• Upper Respiratory Tract Infection
• COVID-19
• Flu
• Flu Like Illness
• Cold

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Elderberry	European black elderberry extract
OTHER	Placebo	Inactive placebo

Timeline

• Start date: 2022-08-26
• Primary completion: 2023-03-28
• Completion: 2023-06-30
• First posted: 2022-06-28
• Last updated: 2022-10-12

Locations

1 site across 1 country: United States